CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 721631-721809 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T8828","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Mutation detection in the EGFR, KRAS, NRAS and BRAF genes is standard of care for targeted therapy of metastatic non-small cell lung cancers (NSCLC) and colorectal cancers (CRC)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T252","span":{"begin":0,"end":178},"obj":"Sentence"}],"text":"Mutation detection in the EGFR, KRAS, NRAS and BRAF genes is standard of care for targeted therapy of metastatic non-small cell lung cancers (NSCLC) and colorectal cancers (CRC)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1569","span":{"begin":113,"end":140},"obj":"Phenotype"},{"id":"T1570","span":{"begin":117,"end":140},"obj":"Phenotype"},{"id":"T1571","span":{"begin":142,"end":147},"obj":"Phenotype"},{"id":"T1572","span":{"begin":173,"end":176},"obj":"Phenotype"}],"attributes":[{"id":"A1569","pred":"hp_id","subj":"T1569","obj":"http://purl.obolibrary.org/obo/HP_0030358"},{"id":"A1570","pred":"hp_id","subj":"T1570","obj":"http://purl.obolibrary.org/obo/HP_0030357"},{"id":"A1571","pred":"hp_id","subj":"T1571","obj":"http://purl.obolibrary.org/obo/HP_0030358"},{"id":"A1572","pred":"hp_id","subj":"T1572","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A1573","pred":"hp_id","subj":"T1572","obj":"http://purl.obolibrary.org/obo/HP_0030731"}],"text":"Mutation detection in the EGFR, KRAS, NRAS and BRAF genes is standard of care for targeted therapy of metastatic non-small cell lung cancers (NSCLC) and colorectal cancers (CRC)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T655","span":{"begin":128,"end":132},"obj":"Body_part"}],"attributes":[{"id":"A655","pred":"uberon_id","subj":"T655","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Mutation detection in the EGFR, KRAS, NRAS and BRAF genes is standard of care for targeted therapy of metastatic non-small cell lung cancers (NSCLC) and colorectal cancers (CRC)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3440","span":{"begin":113,"end":140},"obj":"Disease"},{"id":"T3441","span":{"begin":117,"end":140},"obj":"Disease"},{"id":"T3442","span":{"begin":142,"end":147},"obj":"Disease"},{"id":"T3443","span":{"begin":153,"end":171},"obj":"Disease"},{"id":"T3444","span":{"begin":173,"end":176},"obj":"Disease"},{"id":"T93534","span":{"begin":113,"end":140},"obj":"Disease"},{"id":"T15336","span":{"begin":117,"end":140},"obj":"Disease"},{"id":"T97965","span":{"begin":142,"end":147},"obj":"Disease"},{"id":"T88058","span":{"begin":153,"end":171},"obj":"Disease"},{"id":"T4860","span":{"begin":173,"end":176},"obj":"Disease"}],"attributes":[{"id":"A3440","pred":"mondo_id","subj":"T3440","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A3441","pred":"mondo_id","subj":"T3441","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A3442","pred":"mondo_id","subj":"T3442","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A3443","pred":"mondo_id","subj":"T3443","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A3444","pred":"mondo_id","subj":"T3444","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A3445","pred":"mondo_id","subj":"T3444","obj":"http://purl.obolibrary.org/obo/MONDO_0024331"},{"id":"A71503","pred":"mondo_id","subj":"T93534","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A42236","pred":"mondo_id","subj":"T15336","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A81754","pred":"mondo_id","subj":"T97965","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A9977","pred":"mondo_id","subj":"T88058","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A72058","pred":"mondo_id","subj":"T4860","obj":"http://purl.obolibrary.org/obo/MONDO_0005575"},{"id":"A21139","pred":"mondo_id","subj":"T4860","obj":"http://purl.obolibrary.org/obo/MONDO_0024331"}],"text":"Mutation detection in the EGFR, KRAS, NRAS and BRAF genes is standard of care for targeted therapy of metastatic non-small cell lung cancers (NSCLC) and colorectal cancers (CRC)."}